The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 12, 2019
Filed:
May. 24, 2018
Applicant:
Shionogi & Co., Ltd., Osaka, JP;
Inventors:
Tomokazu Yoshinaga, Osaka, JP;
Kouhei Nodu, Osaka, JP;
Assignee:
SHIONOGI & CO., LTD., Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 513/04 (2006.01); C07D 513/14 (2006.01); A61K 31/4985 (2006.01); A61K 31/53 (2006.01); C07D 471/04 (2006.01); C07D 471/14 (2006.01); C07D 471/22 (2006.01); C07D 498/14 (2006.01); C07D 498/22 (2006.01);
U.S. Cl.
CPC ...
C07D 513/14 (2013.01); A61K 31/4985 (2013.01); A61K 31/53 (2013.01); C07D 471/04 (2013.01); C07D 471/14 (2013.01); C07D 471/22 (2013.01); C07D 498/14 (2013.01); C07D 498/22 (2013.01);
Abstract
The present invention relates to a novel compound having an antiviral effect, more specifically, a pyridone derivative having HIV integrase inhibitory activity, and a medicament containing the same, in particular, an anti-HIV agent. The compound of the present invention has integrase inhibitory activity and/or cell proliferation inhibitory activity against viruses, in particular, HIV and drug-resistant strains thereof. Thus, the compound is useful in preventing or treating various diseases, viral infections (for example, AIDS), and the like in which integrase participates.